Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Dr. Richard Lafayette, founder and director of the Glomerular Disease Center at Stanford University Medical Center, discusses the prevalence and impact of IgA nephropathy, the most common primary…
This video discusses IgA nephropathy (IgAN), a kidney disease where proteins from the immune system build up in the kidney filters, causing inflammation and potential damage. It details…
The CARE1 pragmatic clinical trial was designed to determine the optimal treatment combination for patients with metastatic kidney cancer, using a specific biomarker. The trial, funded by the…
Angela Belcher, PhD; Sangeeta Bhatia, MD, PhD; and Paula Hammond, PhD, from the Koch Institute at MIT, Cambridge, MA, present multi-dimensional approaches to early detection in ovarian cancer.…
Ken Berry, MD, a family physician, discusses polycystic kidney disease (PKD), the most common inherited kidney disease. PKD is characterized by enlarging cysts in the kidney that can…
Polycystic kidney disease (PKD) is a common cause of secondary hypertension, particularly in young people. PKD is a group of disorders, with the most relevant being autosomal dominant…
Mohamed Tinawi, MD, a nephrologist from Northwest Indiana, provides an update from Kidney Week 2023, discussing several significant studies and trials. Results from the DUPLEX trial, published in…
Michael Collins, MBChB, FRACP, PhD, a kidney transplant specialist at the Royal Adelaide Hospital, discusses his research on improving kidney transplant outcomes. He explains that during organ donation,…
Edward P.K. Kwakyi, BSc, and Rasheed A. Gbadegesin, MBBS, MD, FASN, discuss the role of apolipoprotein L1 (APOL1) in kidney diseases, particularly in people of African ancestry. APOL1…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, discusses the treatment of large kidney tumors. Historically, most kidney cancers presented as large masses, but with advancements in…
